SCHEMBL5468640

SCHEMBL5468640

Nc1ncc2c(n1)CC(c1ccccc1-c1cccc(F)n1)CC2=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
MAPT P10636 5/20 0.52
TDP1 Q9NUW8 1/20 0.52
HPGD P15428 5/20 0.52
GAA P10253 1/20 0.44
TSHR P16473 6/20 0.40
HSD17B10 Q99714 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 2/20 0.39
CASP1 P29466 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FGFR1 P11362 1/20 0.39
FGFR2 P21802 1/20 0.39
LMNA P02545 1/20 0.38
USP2 O75604 1/20 0.37
MAPK1 P28482 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780612 0.85 MAPT (0.55) ALDH1A1MAPTTDP1HPGDGAA
SCHEMBL5458101 0.84 HPGD (0.59) ALDH1A1MAPTTDP1HPGDGAA
SCHEMBL1782829 0.84 ALDH1A1 (0.58) ALDH1A1MAPTTDP1HPGDGAA
SCHEMBL1782848 0.83 ALDH1A1 (0.59) ALDH1A1MAPTTDP1HPGDGAA
SCHEMBL5464952 0.81 ALDH1A1 (0.53) ALDH1A1MAPTTDP1HPGDGAA
SCHEMBL1780064 0.81 ALDH1A1 (0.55) ALDH1A1MAPTTDP1HPGDGAA
SCHEMBL14582369 0.81 HSP90AA1 (0.58) ALDH1A1HPGDTSHRHSP90AA1HSP90AB1
SCHEMBL1779376 0.79 MAPT (0.53) ALDH1A1MAPTTDP1HPGDGAA
SCHEMBL1783346 0.78 ALDH1A1 (0.59) ALDH1A1MAPTTDP1HPGDGAA
SCHEMBL10025782 0.78 MAPT (0.59) ALDH1A1MAPTTDP1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027150-A1 2-Amino-quinazolin-5-ones TK1, TK2, SLC1A5 ALDH1A1 1718/4885MAPT 457/4885TDP1 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.